Table 2 |
|||
| Clinical characteristics of participants | |||
| Variable name | Total | ||
| N | % | ||
| Total | – – – – – – | 212 | 100 |
| Suicide attempt | Yes | 96 | 45.3 |
| No | 116 | 54.7 | |
| History of admission | Yes | 143 | 67.5 |
| No | 69 | 32.5 | |
| History of EPSE | Yes | 118 | 55.7 |
| No | 94 | 44.3 | |
| Medication non-adherence | Yes | 128 | 60.4 |
| No | 84 | 39.6 | |
| Contribution of stigma to non-adherence (N = 128)** | Yes | 62 | 48.4 |
| No | 66 | 51.6 | |
| Prominent psychotic symptoms | Yes | 68 | 32.1 |
| No | 144 | 67.9 | |
Abbreviations: EPSE = Extrapyramidal side effects;
**Those without history of non-adherence (N = 84) excluded.
Assefa et al. BMC Psychiatry 2012 12:239 doi:10.1186/1471-244X-12-239